Table 3.
Outcomes at 1-year follow up.
Variable | Before project at 1 year [7] (n = 120) | After project at 1 year (n = 273) | P-value |
---|---|---|---|
Secondary fractures | 36 (30.0%) | 8 (2.93%) | < 0.001∗ |
Post-injury osteoporotic medications | |||
No | 71 (59.2%) | 29 (10.62%) | < 0.001∗ |
Yes | 49 (40.8%) | 244 (89.38%) | |
Calcium or vitamin D | 0 (0.0%) | 26 (9.53%) | |
Calcium and vitamin D | 25 (20.8%) | 225 (82.42%) | |
Bisphosphonate | 18 (15.0%) | 15 (5.49%) | |
Denosumab | 0 (0.0%) | 78 (28.57%) | |
Teriparatide | 6 (5.0%) | 29 (10.63%) | |
Others (Vit K2, Calcitonin) |
0 (0.0%) |
7 (2.57%) |
|
Post-injury falls, time | NA | 0.1 (Min 0, Max 1) | NA |
Values are presented as number (%).
NA, not assessed; Vit, vitamin; ∗statistically significant.